ACI’s Hatch-Waxman Series Advisory Board
American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.
Ryan M. Daniel
VP, Associate General Counsel, Corporate and Business TransactionsBiopharmaceuticals Fresenius Kabi LLC
Laura DeMoor
Senior Counsel Baxter Healthcare
Stephanie Donahue
Principal Counsel – Global PatentLitigation, Global IP Department
Legal, Ethics & Business Integrity Sanofi-Aventis
Serena Farquharson-Torres
Executive Director, Assistant General CounselInnovation Law Bristol Myers Squibb
Linda Friedlieb
Division Counsel AbbVie
Colin C. Heitzmann
Vice President, IP and Business Development Daiichi Sankyo, Inc.
Jenny Johnson
Vice President, IP Endo Pharmaceuticals
Staci Julie
SVP and Chief IP Counsel Teva Pharmaceuticals
Neema Kumar
Vice President, IP, North America Sandoz
James P. Leeds
Vice President and Chief Patent Counsel – Hatch Waxman Litigation Eli Lilly & Company
Mary J. Morry
Counsel, IP Litigation Merck Sharp & Dohme LLC
Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel Pfizer Inc
Aaron Pereira
Senior Director of Patents Ferring Pharmaceuticals
Brian Stone
Vice PresidentAssistant Global General Counsel Regulatory Mylan
Lars P. Taavola
VP, Chief IP Counsel & GeneralCounsel, Specialty Generics Mallinckrodt Pharmaceuticals
Andrea D. Tiglio, PhD, JD
Executive DirectorAssistant General Counsel, Intellectual Property Jazz Pharmaceuticals
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Policy Amneal Pharmaceuticals
Kevin Zive
Vice President, General Counsel, and Head of Global Intellectual Property Apotex Inc.Emeritus Members
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation Taft Stettinius & Hollister LLP(Former Vice President, IP, Sandoz, Inc.)
Guy Donatiello
Principal Odyssey Pharmaceuticals Consulting (Former SVP, IP, Endo Pharmaceuticals)
George W. Johnston
Counsel Gibbons P.C.(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)
Honorable Kathleen M. O’Malley (Ret.)
Of Counsel Sullivan & Cromwell LLP Former United States Circuit Judge, U.S. Court of Appeals for the Federal Circuit
Honorable Teresa Rea
Consultant Rea Consulting LLC Former Acting Director of the USPTO
Shashank Upadhye
Partner Upadhye Tang LLP Former Vice President – Global Intellectual Property, Apotex, Inc.